<code id='81F4994F34'></code><style id='81F4994F34'></style>
    • <acronym id='81F4994F34'></acronym>
      <center id='81F4994F34'><center id='81F4994F34'><tfoot id='81F4994F34'></tfoot></center><abbr id='81F4994F34'><dir id='81F4994F34'><tfoot id='81F4994F34'></tfoot><noframes id='81F4994F34'>

    • <optgroup id='81F4994F34'><strike id='81F4994F34'><sup id='81F4994F34'></sup></strike><code id='81F4994F34'></code></optgroup>
        1. <b id='81F4994F34'><label id='81F4994F34'><select id='81F4994F34'><dt id='81F4994F34'><span id='81F4994F34'></span></dt></select></label></b><u id='81F4994F34'></u>
          <i id='81F4994F34'><strike id='81F4994F34'><tt id='81F4994F34'><pre id='81F4994F34'></pre></tt></strike></i>

          entertainment

          entertainment

          author:explore    Page View:4795
          CRISPR Cancer Risk
          Adobe

          The Food and Drug Administration said on Friday that it has some safety concerns about an experimental CRISPR-based treatment for sickle cell disease, citing the methods used by its makers to evaluate the risk of inadvertently making unwanted changes to patients’ DNA.

          None of the concerns raised by the FDA on Friday, however, suggest the agency is reluctant to approve the treatment, called exa-cel, which is being developed by Vertex Pharmaceuticals and CRISPR Therapeutics.

          advertisement

          Exa-cel, given as a one-time infusion, uses CRISPR genome-editing technology to patch up the genetic faults at the root of sickle cell disease.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          Virginia high school admissions case could be legal follow
          Virginia high school admissions case could be legal follow

          3:24DemonstratorsprotestoutsideoftheSupremeCourtinWashington,Thursday,June29,2023,aftertheSupremeCou

          read more
          A new ‘biological computer' targets cancer while sparing healthy cells
          A new ‘biological computer' targets cancer while sparing healthy cells

          AdobeTheholygrailofcancerdrugtargetsisakintoaunicornhorn:amarkerthatonlycancercellshave,clearlydisti

          read more
          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more

          This biotech could one day make human eggs from scratch. But first, they’re trying to rethink IVF

          Aneggisexaminedduringtheprocessofinvitrofertilization.Gameto,abiotechstartup,hasdevelopedaproductcal